Stay updated on CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial
Sign up to get notified when there's something new on the CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial page.

Latest updates to the CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial page
- Check2 days agoChange DetectedThe history shows an administrative funding notice and a new revision tag (v3.4.1) for the record. These changes are metadata and do not alter the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1.0%

- Check9 days agoChange DetectedThe Record History page now includes a glossary toggle and color-coded change indicators (green for additions, red for deletions) with a revision label showing v3.4.0. 'No FEAR Act Data' was removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed in the Record History, reflecting metadata updates rather than substantive study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedFooter updated: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2; no study data or record history content changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check67 days agoChange DetectedNew revision entry v3.3.2 was added and v3.3.1 was removed in the Record History. This is a versioning update and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check74 days agoChange DetectedThe record history shows an added revision v3.3.1 and a removed revision v3.2.0.SummaryDifference0.1%

Stay in the know with updates to CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT103A in High-risk Multiple Myeloma: FUMANBA-2 Clinical Trial page.